<DOC>
	<DOCNO>NCT01566578</DOCNO>
	<brief_summary>Investigation EGF-Receptor Downregulation topical EGF ( dermal cream ) exposition .</brief_summary>
	<brief_title>A Physiological Study Downregulation EGF-receptors Skin Topical Exposition With EGF</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Informed consent Mild moderate psoriasis ( type ) active plaque body side accessible biopsy self product application EGFR immunohistochemistry score &gt; 5 Male Age 1860 year Systemic psoriasis treatment 3 month prior study Local psoriasis treatment investigational site last 30 day study Known hypersensitivity allergy EGF contain product ( Newskin ) and/or Vaseline/10 % salicylic acid and/or local anaesthetic amid type Known suspect noncompliance study protocol Coagulopathy treatment anticoagulant History malignant disease Other clinically relevant concomitant disease state Participation another investigational drug study last 30 day</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>